Exactech Names Orthopaedic Executive Bill Shopoff as Vice President U.S. Sales; Industry Veteran Bob Purcell Retires After 40...
October 14 2013 - 1:45PM
Business Wire
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone
and joint restoration products for hip, knee, shoulder, spine and
biologic materials, announced today the appointment of Bill Shopoff
as vice president of U.S. sales for large joints. The appointment
is effective today.
A 30-year veteran of the orthopaedic industry, Shopoff has
provided global sales and business leadership for Smith &
Nephew since 1984, most recently serving as president of the Trauma
and Extremities franchise.
He replaces Bob Purcell who will retire after more than 40 years
in orthopaedics and healthcare capital equipment sales. During
Purcell’s six years as Exactech’s vice president of U.S. Sales, he
strengthened the domestic sales team and led the organization to a
compound annual growth rate of 10 percent.
“Bill Shopoff’s extensive experience in orthopaedic sales
management is complemented by strong business leadership. These
skills make him uniquely suited to build on the strong foundation
that Bob Purcell has established within our domestic sales
organization,” said Exactech President David Petty. “We have great
appreciation for Bob Purcell’s contributions and plan to continue
to leverage his expertise in strategic accounts contracting by
engaging him as a consultant.”
About Exactech
Based in Gainesville, Fla., Exactech develops and markets
orthopaedic implant devices, related surgical instruments and
biologic materials and services to hospitals and physicians. The
company manufactures many of its orthopaedic devices at its
Gainesville facility. Exactech’s orthopaedic products are used in
the restoration of bones and joints that have deteriorated as a
result of injury or diseases such as arthritis. Exactech markets
its products in the United States, in addition to more than 30
markets in Europe, Latin America, Asia and the Pacific. Additional
information about Exactech, Inc. can be found at
http://www.exac.com. Copies of Exactech’s press releases, SEC
filings, current price quotes and other valuable information for
investors may be found at http://www.exac.com and
http://www.hawkassociates.com.
An investment profile on Exactech may be found at
http://www.hawkassociates.com/profile/exac.cfm. To receive future
releases in e-mail alerts, sign up at
http://www.hawkassociates.com/about/alert.
This release contains various forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934, which represent
the company’s expectations or beliefs concerning future events of
the company’s financial performance. These forward-looking
statements are further qualified by important factors that could
cause actual results to differ materially from those in the
forward-looking statements. These factors include the effect of
competitive pricing, the company’s dependence on the ability of
third party manufacturers to produce components on a basis which is
cost-effective to the company, market acceptance of the company’s
products and the effects of government regulation. Results actually
achieved may differ materially from expected results included in
these statements.
Exactech, Inc.Jody Phillips, 352-377-1140Chief Financial
OfficerorHawk AssociatesJulie Marshall or Frank Hawkins,
305-451-1888exactech@hawkassociates.com
Exactech, Inc. (delisted) (NASDAQ:EXAC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Exactech, Inc. (delisted) (NASDAQ:EXAC)
Historical Stock Chart
From Apr 2023 to Apr 2024